Alba Biologics Group’s extensive experience in opportunity evaluation and strategic planning enables its clients to transition their products from discovery to the clinic and to commercialization faster and with less expense and risk. Whether your product is in the research laboratory, pre-clinical development or already in clinical trials, we can help increase its value by working with your staff or independently to plan and manage the forward progress of your drug to the commercial market.

Alba Biologics brings unique experience in the areas of both biosimilar drugs and therapeutic countermeasures to bioterrorism to complement expertise in traditional biological drug development.